Alnylam Pharmaceuticals Inc (ALNY) — Strategic Asset Allocation Index
Alnylam Pharmaceuticals Inc (ALNY) has a Strategic Asset Allocation Index of 415.9% as of June 2022. Strategic assets (PP&E of $732.12 Million plus long-term investments of $-) total $732.12 Million, measured against net assets of $176.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see ALNY company net worth.
SAAI
Strategic Assets
PP&E
Net Assets
Alnylam Pharmaceuticals Inc Strategic Asset Allocation Index (2004–2021)
This chart shows how Alnylam Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2004 to 2021. As of June 2022, the index stands at 415.9%, representing strategic assets of $732.12 Million against net assets of $176.04 Million USD. See Alnylam Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Alnylam Pharmaceuticals Inc (2004–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Alnylam Pharmaceuticals Inc from 2004 to 2021, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore ALNY year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 85.3% | $501.96 Million | $501.96 Million | $- | $588.20 Million | ▲ +39.6 pp |
| 2020 | 45.8% | $465.03 Million | $465.03 Million | $- | $1.02 Billion | ▲ +15.2 pp |
| 2019 | 30.6% | $440.00 Million | $425.18 Million | $14.82 Million | $1.44 Billion | ▲ +6.0 pp |
| 2018 | 24.6% | $320.66 Million | $320.66 Million | $0.00 | $1.30 Billion | ▲ +13.5 pp |
| 2017 | 11.1% | $195.82 Million | $181.90 Million | $13.92 Million | $1.77 Billion | ▼ -36.7 pp |
| 2016 | 47.7% | $439.37 Million | $114.57 Million | $324.80 Million | $920.22 Million | ▲ +25.6 pp |
| 2015 | 22.1% | $279.65 Million | $27.81 Million | $251.84 Million | $1.26 Billion | ▼ -10.1 pp |
| 2014 | 32.2% | $301.56 Million | $21.74 Million | $279.82 Million | $936.27 Million | ▼ -29.4 pp |
| 2013 | 61.6% | $166.50 Million | $16.45 Million | $150.05 Million | $270.35 Million | ▼ -30.3 pp |
| 2012 | 91.9% | $123.22 Million | $19.80 Million | $103.42 Million | $134.05 Million | ▼ -17.9 pp |
| 2011 | 109.8% | $129.61 Million | $14.64 Million | $114.97 Million | $118.00 Million | ▲ +22.2 pp |
| 2010 | 87.6% | $138.68 Million | $18.29 Million | $120.39 Million | $158.23 Million | ▲ +77.3 pp |
| 2009 | 10.3% | $18.32 Million | $18.32 Million | $- | $177.97 Million | ▲ +0.8 pp |
| 2008 | 9.5% | $19.19 Million | $19.19 Million | $- | $202.12 Million | ▲ +2.6 pp |
| 2007 | 6.9% | $13.81 Million | $13.81 Million | $- | $199.17 Million | ▲ +0.9 pp |
| 2006 | 6.1% | $12.17 Million | $12.17 Million | $- | $201.17 Million | ▼ -11.1 pp |
| 2005 | 17.1% | $10.58 Million | $10.58 Million | $- | $61.78 Million | ▼ -8.2 pp |
| 2004 | 25.3% | $11.69 Million | $11.69 Million | $- | $46.14 Million | — |